VEEV - Veeva Systems Inc.

NYSE - NYSE Delayed Price. Currency in USD
146.68
+1.97 (+1.36%)
At close: 4:02PM EST

146.68 0.00 (0.00%)
After hours: 5:17PM EST

Stock chart is not supported by your current browser
Trade prices are not sourced from all markets
Previous Close144.71
Open144.70
Bid146.40 x 800
Ask148.00 x 1000
Day's Range144.61 - 147.71
52 Week Range79.26 - 176.90
Volume1,020,787
Avg. Volume1,510,172
Market Cap21.706B
Beta (3Y Monthly)1.25
PE Ratio (TTM)80.64
EPS (TTM)1.82
Earnings DateNov. 26, 2019
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est175.63
  • Veeva Systems (VEEV) Outpaces Stock Market Gains: What You Should Know
    Zacks

    Veeva Systems (VEEV) Outpaces Stock Market Gains: What You Should Know

    Veeva Systems (VEEV) closed the most recent trading day at $146.67, moving +1.35% from the previous trading session.

  • Veeva Acquires Physicians World
    Business Wire

    Veeva Acquires Physicians World

    Veeva Systems (VEEV) today announced it has acquired Physicians World, a leading provider of speakers bureau services. Veeva and Physicians World are joining forces to meet the industry’s need for a complete solution to plan and execute live and virtual events for healthcare professionals. Together, the companies are combining industry-leading cloud software and services to streamline events management and compliance.

  • Business Wire

    Almirall Makes Shift to Specialty Medicine with Veeva CRM 

    Veeva Systems (VEEV) today announced that Almirall selected multichannel Veeva CRM to deliver seamless customer experience across all channels as it shifts business focus to specialty medicine. Almirall’s adoption of multichannel Veeva CRM builds upon their success with Veeva Vault PromoMats, which the company is using for commercial content and digital asset management. “We recently shifted our business strategy from primary care to specializing in dermatology and skin disease, requiring us to target a completely different set of customers,” said Carlos Sosa, director of global sales operations excellence at Almirall.

  • Business Wire

    Almirall Makes Shift to Specialty Medicine with Veeva CRM

    Spain’s leading pharmaceutical company drives seamless customer engagement across multiple stakeholders using face-to-face, email, and web

  • Business Wire

    Veeva to Release Fiscal 2020 Third Quarter Results on November 26, 2019

    Veeva Systems will announce financial results for its third quarter which ended October 31, 2019 after the market close on November 26, 2019. Veeva will host a conference call and webcast that day at 1:30 p.m.

  • Business Wire

    Veeva Completes Acquisition of Crossix

    Veeva Systems (VEEV) today announced it has completed its acquisition of Crossix Solutions. Trusted by more than 200 pharmaceutical brands, Crossix provides privacy-safe U.S. patient data and a best-in-class analytics platform to help maximize media and marketing effectiveness. “We’re excited to welcome the talented Crossix team to the Veeva family,” said Veeva founder and CEO Peter Gassner.

  • Why the Earnings Surprise Streak Could Continue for Veeva (VEEV)
    Zacks

    Why the Earnings Surprise Streak Could Continue for Veeva (VEEV)

    Veeva (VEEV) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

  • Veeva Systems Sees Hammer Chart Pattern: Time to Buy?
    Zacks

    Veeva Systems Sees Hammer Chart Pattern: Time to Buy?

    Veeva Systems has been struggling lately, but the selling pressure may be coming to an end soon.

  • Business Wire

    Global Survey Finds CROs Undergoing Major Changes to Speed Clinical Trials

    CROs eliminating manual processes and modernizing systems to streamline information exchange and accelerate study start-up

  • Is Veeva Systems (VEEV) Stock Outpacing Its Computer and Technology Peers This Year?
    Zacks

    Is Veeva Systems (VEEV) Stock Outpacing Its Computer and Technology Peers This Year?

    Is (VEEV) Outperforming Other Computer and Technology Stocks This Year?

  • Did The Underlying Business Drive Veeva Systems's (NYSE:VEEV) Lovely 394% Share Price Gain?
    Simply Wall St.

    Did The Underlying Business Drive Veeva Systems's (NYSE:VEEV) Lovely 394% Share Price Gain?

    While Veeva Systems Inc. (NYSE:VEEV) shareholders are probably generally happy, the stock hasn't had particularly good...

  • Software Names Slide as Atlassian Fails to Ease Valuation Fears
    Bloomberg

    Software Names Slide as Atlassian Fails to Ease Valuation Fears

    (Bloomberg) -- Software companies fell on Friday, extending recent losses after results from Atlassian Corp. topped analyst forecasts yet failed to provide enough upside to assuage concerns over the group’s valuation.Atlassian shares dropped as much as 11% to their lowest level since May. The stock was on track for its third straight decline, as was Veeva Systems Inc., off 5.4%, and ServiceNow Inc., down 3.8%, which reports its own results next week. Coupa Software Inc. sank 8.4% in its fourth straight drop, a period over which it has shed more than 20% of its valuation. Twilio Inc. was down 4.5%. Alteryx Inc. was down 7.2% and Crowdstrike Holdings Inc. dropped 7.3%, heading for the eighth decline in the past nine sessions.A basket of high-multiple software stocks tracked by Goldman Sachs fell 5.7% in its fifth straight decline, hitting its lowest since March, while the Russell Midcap Technology Growth Index was down 2.2%.“When investors have lost conviction, it usually means the best strategy is to stay conservative until the coast is at least somewhat clear,” wrote Richard Davis, an analyst at Canaccord Genuity. “We are in that time in the cycle.”Davis has a buy rating on Atlassian, writing that it “fits the description of a safe harbor company.” However, he said the stock has a “high-ish valuation” and suggested that multiples could be hard to justify. “In this macro environment,” he wrote, “if anyone expected an over-sized guide up, they haven’t been paying attention.”Recent weakness in the sector included both Workday Inc. and Zoom Video Communications Inc. tumbling in the wake of their respective investor events, which underlined growth concerns.Atlassian’s results included a raised full-year revenue forecast, and Cowen wrote that this could ease broader concerns over the sector.This “was one of the more anticipated prints in software as a result of emerging macro concerns in the space and it being one of the first to report,” analyst J. Derrick Wood wrote. The “solid numbers & outlook, along with constructive commentary on stable demand conditions, should give investors greater comfort in the potential for stability in software spending.”To contact the reporter on this story: Ryan Vlastelica in New York at rvlastelica1@bloomberg.netTo contact the editors responsible for this story: Catherine Larkin at clarkin4@bloomberg.net, Jim SilverFor more articles like this, please visit us at bloomberg.com©2019 Bloomberg L.P.

  • Veeva Systems (VEEV) Stock Sinks As Market Gains: What You Should Know
    Zacks

    Veeva Systems (VEEV) Stock Sinks As Market Gains: What You Should Know

    Veeva Systems (VEEV) closed the most recent trading day at $148.89, moving -0.66% from the previous trading session.

  • Veeva Systems (VEEV) Gains But Lags Market: What You Should Know
    Zacks

    Veeva Systems (VEEV) Gains But Lags Market: What You Should Know

    In the latest trading session, Veeva Systems (VEEV) closed at $150.25, marking a +0.62% move from the previous day.

  • Veeva Announces Free eRegulatory Solution for Clinical Research Sites
    Business Wire

    Veeva Announces Free eRegulatory Solution for Clinical Research Sites

    Veeva Systems (VEEV) today announced Veeva SiteVault Free, a free eRegulatory solution built specifically for clinical research sites. Now all sites can have access to a modern cloud solution to streamline trial activities and accelerate clinical research. “Veeva aims to simplify study execution so sites can focus on the critical work of clinical research and patient care,” said Peter Gassner, founder and CEO of Veeva.

  • Business Wire

    Repsco, Largest Contract Sales Organization in France, Selects Veeva CRM for Better Customer Engagement

    Veeva Systems (VEEV) today announced that Repsco, the largest contract sales organization in France, has standardized on Veeva CRM for all their teams. A longtime partner to the life sciences industry, Repsco’s skilled medical reps help more than 30 companies bring their medicines to market. “We are committed to empowering our reps with industry leading solutions," said Philippe Tascher, general manager of Repsco.

  • Veeva Systems to Improve Patient Outcome With Crossix Buyout
    Zacks

    Veeva Systems to Improve Patient Outcome With Crossix Buyout

    The latest acquisition fortifies Veeva Systems' (VEEV) foothold in the HCIT space further.

  • Why Veeva Systems Inc. (NYSE:VEEV) Looks Like A Quality Company
    Simply Wall St.

    Why Veeva Systems Inc. (NYSE:VEEV) Looks Like A Quality Company

    One of the best investments we can make is in our own knowledge and skill set. With that in mind, this article will...

  • Veeva (VEEV) Down 5.4% Since Last Earnings Report: Can It Rebound?
    Zacks

    Veeva (VEEV) Down 5.4% Since Last Earnings Report: Can It Rebound?

    Veeva (VEEV) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.